Impax Laboratories to Appear at the RBC Capital Markets Healthcare Conference on Tuesday, March 2, 2010

February 26, 2010

HAYWARD, Calif., Feb 26, 2010 (BUSINESS WIRE) -- Impax Laboratories, Inc.(NASDAQ: IPXL) today announced that Arthur A. Koch, Jr., its senior vice president and chief financial officer, will appear on the Generically Speaking panel at the RBC Capital Markets 2010 Healthcare Conference on Tuesday, March 2nd, at 1:35 p.m. Eastern Standard time. The conference will be held at the New York Palace Hotel, New York.

Individuals may listen to the live or archived event which will be posted in the investor relations section of the Company's web site at This event will be archived on the Company's web site for 30 days.

About Impax Laboratories, Inc.

Impax Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at:

SOURCE: Impax Laboratories, Inc.

Impax Laboratories, Inc.
Mark Donohue, Sr. Director Investor Relations